"10.1371_journal.pone.0087398","plos one","2014-01-27T00:00:00Z","Stephanie R Shepheard; Tim Chataway; David W Schultz; Robert A Rush; Mary-Louise Rogers","Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, South Australia, Australia; Neurology Department and MND Clinic, Flinders Medical Centre, Bedford Park, South Australia, Australia","Conceived and designed the experiments: RAR TC MLR. Performed the experiments: MLR SRS. Analyzed the data: SRS MLR. Contributed reagents/materials/analysis tools: DWS. Wrote the paper: MLR.","Flinders University has submitted a patent: Flinders University Australia, Rush R, Rogers M-L, Shepheard S, Chataway T. Biomarker for Motor Neuron Disease. No 2011900312 PCT. Flinders University: Australia; at national phase 2013. Robert R Rush is Managing Director of Biosensis Pty Ltd, Adelaide, which sells MLR2 antibody. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","01","Stephanie R Shepheard","SRS",5,TRUE,3,2,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
